Aakaar Medical Technologies Ltd

Aakaar Medical Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Aakaar Medical Technologies Ltd

₹ 75.4 -3.71%
16 Jul 3:57 p.m.
aakaarmedical.in NSE - SME: AAKAAR
About

Incorporated in June 2013, Aakaar Medical Technologies Limited is an aesthetic medical company that offers a diverse selection of specialized cosmetic products and devices.[1]

Key Points

Business Profile[1]
Aakaar Medical Technologies operates in the medical aesthetics segment, offering a portfolio of aesthetic products and devices through a B2B model. It caters primarily to dermatologists, plastic surgeons, and aesthetic physicians across India.

Website NSE - SM
  • Market Cap ₹ 107 Cr.
  • Current Price ₹ 75.4
  • High / Low ₹ 81.4 / 62.0
  • Stock P/E 17.7
  • Book Value ₹
  • Dividend Yield 0.00 %
  • ROCE 26.7 %
  • ROE 33.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 29.2%

Cons

  • Promoter holding has decreased over last quarter: -24.1%
  • Company has high debtors of 166 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Fast Moving Consumer Goods Fast Moving Consumer Goods Personal Products Personal Care

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
12.44 19.47 32.78 46.11 61.58
11.54 17.07 29.25 41.11 51.84
Operating Profit 0.90 2.40 3.53 5.00 9.74
OPM % 7.23% 12.33% 10.77% 10.84% 15.82%
0.12 0.04 0.09 0.16 0.18
Interest 0.23 0.21 0.43 1.14 1.71
Depreciation 0.03 0.02 0.09 0.14 0.12
Profit before tax 0.76 2.21 3.10 3.88 8.09
Tax % 28.95% 26.24% 30.65% 26.29% 25.22%
0.54 1.62 2.15 2.87 6.04
EPS in Rs 54.00 23.14 30.71 41.00 5.80
Dividend Payout % 0.00% 34.57% 24.42% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 47%
TTM: 34%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 55%
TTM: 110%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 29%
Last Year: 34%

Balance Sheet

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.10 0.70 0.70 0.70 10.42
Reserves 7.30 7.33 8.96 11.84 12.78
3.88 3.82 5.87 15.05 22.74
3.03 6.15 7.70 6.42 8.17
Total Liabilities 14.31 18.00 23.23 34.01 54.11
0.04 0.20 0.36 0.28 0.24
CWIP 0.00 0.00 0.00 0.00 0.00
Investments 0.11 0.00 0.00 0.00 0.00
14.16 17.80 22.87 33.73 53.87
Total Assets 14.31 18.00 23.23 34.01 54.11

Cash Flows

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
4.31 0.48 -2.93 -8.04 -5.41
0.37 -0.23 -0.32 -0.04 -0.05
-2.00 -0.81 1.17 8.19 10.71
Net Cash Flow 2.68 -0.55 -2.08 0.11 5.25

Ratios

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 135.85 104.42 113.91 128.71 165.96
Inventory Days 366.16 281.70 273.75 247.29 202.47
Days Payable 98.96 65.19 61.56 31.74 48.84
Cash Conversion Cycle 403.05 320.92 326.10 344.26 319.59
Working Capital Days 238.25 176.78 166.91 213.17 231.64
ROCE % 20.93% 25.79% 23.28% 26.66%

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2025
67.01%
1.87%
12.33%
18.79%
No. of Shareholders 920

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

No data available.